ClinicalTrials.govpublic full text
Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
papillary renal cell carcinoma, unclassified renal cell carcinoma, translocation renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct renal cell carcinoma, renal cell carcinoma, unresectable advanced renal cell carcinoma, metastatic ncc renal cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850444
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.